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Inferior vena cava (IVC) leiomyosarcoma is a rare cancer treated with wide surgical resection. IVC leiomyomatosis is a
benign tumor treated with open caval excision. A patient with an IVC tumor with iliocaval thrombosis was treated with
thrombolysis and iliac stents. The patient was sent 1 year later to our institution with an IVC mass. Transvenous biopsy
was consistent with leiomyomatosis. At surgery, the lesion was adherent, resected and the IVC reconstructed. Pathologic
evaluation documented well-differentiated leiomyosarcoma not leiomyomatosis. Thorough evaluation of iliocaval
thrombosis is recommended before endovascular management. Diagnostic modalities may be inadequate to differentiate
leiomyosarcoma from leiomyomatosis. (J Vasc Surg 2002;36:1256-9.)
Intravenous leiomyomatosis, a benign smooth muscle
cell tumor of uterine origin, grows into the venous channels
of women. This tumor has been reported numerous times
to extend into the inferior vena cava (IVC). Leiomyosar-
coma of the IVC, a rare cancer of smooth muscle cell origin,
also occurs predominantly in women. Both leiomyomatosis
and leiomyosarcoma of the IVC are associated with uterine
disease. Diagnostic evaluation for these disease processes is
similar with ultrasound scan, computed tomographic (CT)
scan, magnetic resonance imaging (MRI), and venography.
Operative treatment of these tumors is quite different.
Leiomyomatosis is treated with hysterectomy, bilateral sal-
pingooophorectomy, and transvenous excision of all extra-
uterine tumors. Leiomyosarcoma of the IVC is treated with
wide local excision.
A case of a pararenal IVC tumor with iliocaval throm-
bosis and treated with prosthetic replacement of the cava is
discussed. Potential diagnostic modalities to preoperatively
differentiate leiomyomatosis and leiomyosarcoma are re-
viewed.
CASE REPORT
A 44-year-old female truck driver was seen at an outside
hospital in July 2000 with a 1-week history of abdominal pain
radiating to her back with associated claudication. The symptoms
developed after a 1000-mile trip in her truck. CT scan performed
to rule out diverticulitis revealed thrombosis of the internal iliac
veins extending to the pararenal vena cava. The patient was treated
with catheter-based thrombolytic therapy, bilateral common iliac
vein stents, and anticoagulation. Completion venography docu-
mented persistent narrowing of the IVC at the L2 level without
evidence of extrinsic compression. The patient was placed on
life-long warfarin therapy, despite a negative evaluation for hyper-
coagulability.
The patient stopped the warfarin therapy in September 2001
because of menometrorrhagia. Over the ensuing 2 weeks, symp-
toms of bilateral flank and back pain radiating to both lower
extremities developed. Review of systems was negative for short-
ness of breath, extremity swelling, recent long-distance travel,
weight loss, or fever. The patient did report abdominal pain,
dyspareunia, or postcoital bleeding. Physical examination revealed
mild left lower quadrant tenderness, no peripheral edema, and a
normal arterial examination. Venous duplex scan examination
documented bilateral popliteal deep venous thrombosis. CT scan
documented iliocaval thrombosis with an IVC mass (Fig 1). The
patient was transferred to our hospital.
Gynecologic examination revealed an enlarged uterus suspi-
cious for uterine leiomyomas. Inferior vena cavography found
bilateral iliac and IVC occlusion (Fig 2). Transvenous biopsy
confirmed a firm mass in the IVC. The biopsy revealed smooth
muscle cells arranged in a fascicular pattern without necrosis or
mitotic activity, consistent with leiomyomatosis.
After the patient underwent total abdominal hysterectomy
with bilateral salpingooophorectomy, proximal and distal control
of the IVC was achieved. Vena cavotomy found an adherent, firm,
whitish, rubbery mass emanating from the posterior of the vena
cava. The mass involved the entire posterior pararenal vena cava
except for the right lateral wall at the right renal vein orifice.
Because of the adherence of the tumor, the pararenal vena cava and
left renal vein were resected. The distal IVC was thrombosed and
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not involved with the tumor. Bilateral iliac thrombectomies were
performed with excellent restoration of flow. The IVC was recon-
structed with an 18-mm polytetrafluoroethylene graft with a
10-mm polytetrafluoroethylene left renal side arm. The right renal
vein orifice was incorporated with the proximal anastomosis. Post-
operative recovery was uncomplicated.
Pathologic evaluation of the IVC mass revealed a 6-cm 
4.6-cm  4.4-cm pinkish-white, lobulated, moderately circum-
scribed, and encapsulated fibrous tumor in conjunction with 10 cm
of IVC. Histologically, the tumor consisted of a solid spindle-cell
lesion comprised of elongated spindled nuclei arranged in interwo-
ven fascicles (Fig 3). Special stains revealed strong cytoplasmic
actin staining, focally positive desmin, scant focally positive vimen-
tin, positive neuron specific enolase, positive CD 34, and negative
S100. All margins were negative for tumor. Pericaval lymph nodes
revealed inflammation without evidence of malignant disease. The
uterus contained a leiomyoma, and examination of the myome-
trium failed to identify any evidence of leiomyomatosis or leiomy-
osarcoma. On the basis of the histologic morphology, immuno-
phenotype, nuclear pleomorphism, focal necrosis, and mitotic rate,
the intraluminal IVC mass was classified as a well-differentiated
leiomyosarcoma, not leiomyomatosis.
DISCUSSION
IVC leiomyomatosis and leiomyosarcoma are rare dis-
eases that occur predominantly in women. Both may cause
symptoms secondary to iliocaval obstruction. Patients are
almost always symptomatic at presentation, although both
tumors show extensive growth before causing symptoms.
The reported case shows that the preoperative differentia-
tion of these two diseases may be difficult.
Birsch-Hirschfeld1 first reported leiomyomatosis in
1896. Leiomyomatosis was defined by Norris and Parmley2
in 1975 as leiomyoma arising from the wall of uterine veins
or uterine leiomyoma infiltrating the venous wall.
Leiomyomatosis only occurs in women, supporting the
theory of a myoma infiltrating the venous system. A recent
report identified a unique vascular architecture found in
52% of hysterectomy specimens where arteries are found
within venous channels in the myometrium.3
The tumor is usually confined to the pelvic veins but
may extend up the IVC to the heart.4 Symptoms may
develop years after previous hysterectomy, with series
showing prior hysterectomy in 56% to 66% of patients.5,6
Symptoms include pelvic pain, abnormal vaginal bleeding,
venous obstruction, heart failure, dyspnea, and sudden
death.4-6 Evaluation with CT, MRI, venography, and
transesophageal echocardiography may be useful.
Leiomyomatosis is rarely adherent to the IVC but usually
does attach to uterine, hypogastric, or common iliac veins.
This tumor is treated with complete transcaval excision,
total abdominal hysterectomy, and bilateral salpin-
gooophorectomy.
Incomplete excision frequently results in recurrence.2
Intravenous leiomyomatosis seems to be hormone depen-
dent with estradiol receptors being present.7 Recurrence of
leiomyomatosis has been associated with functioning ova-
ries resulting in the recommendation for bilateral salpin-
gooophorectomy.8 Hormone suppression with a gonado-
tropin-releasing hormone agonist resulted in tumor
regression of incompletely excised leiomyomatosis in one
report.9
Pathologically, intravenous leiomyomatosis may vary
from firm to soft and spongy. The tumors contain thick-
walled muscular vessels.4 Histologically, the smooth mus-
cle cells are typical for leiomyoma with a whorled pattern
without nuclear pleomorphism. Mitotic activity is no
greater than 1 per 15 high-power fields.2
Primary venous leiomyosarcoma (PVL) is extremely
rare, with the first case reported by Perl10 in 1871. IVC
PVL accounts for 48% to 60% of vascular sarcomas.11,12
Women account for 75% to 90% of IVC PVL.12,13 The
distribution of primary IVC leiomyosarcoma is described in
relation to the renal and hepatic veins, with segment I being
infrarenal, segment II being suprarenal, and segment III
being suprahepatic.12 In a review of 144 cases, 34% oc-
curred in segment I and 41.7% occurred in segment II.14
Our case involved both segments I and II. Most patients are
symptomatic at presentation with abdominal pain, lower
extremity edema, weight loss, or Budd-Chiari syn-
drome.12,14,15 Unfortunately, tumors frequently grow to a
large size before producing symptoms.
Imaging evaluation of PVL includes ultrasound scan,
CT scan , MRI, and venacavography.16,17 Ultrasound scan
may detect the tumor as a hypoechoic mass and confirm
Fig 1. A, Abdominal CT scan showing mass in IVC with com-
pression of left renal vein. B, Abdominal CT scan showing throm-
bosed bilateral iliac vein stents.
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vessel patency. CT scan and MRI provide excellent ana-
tomic detail. Venacavography provides anatomic detail and
allows transvenous biopsy.
IVC leiomyosarcoma is treated with wide local excision
resulting in clear margins. In patients with clear margins,
extended venous resection did not influence local recur-
rence rate or long-term outcome.18 Poor prognostic fac-
tors include segment III location, Budd-Chiari syndrome,
intraluminal tumor growth, and IVC occlusion.19 Resec-
tion with negative margins has consistently shown im-
Fig 2. A, Venacavogram revealing bilateral thrombosed iliac veins and IVC. Lumbar collaterals are noted. B,
Venacavogram revealing patent right renal vein with filling defect in pararenal IVC. Left renal vein is not visualized.
Fig 3. Histology from grade I IVC leiomyosarcoma is shown for hematoxylin and eosin, smooth muscle cell actin, and
desmin stains at 40 power. Tumor consisted of elongated spindled cells with hyperchromatic, enlarged, and irregular
nuclei with small focal areas of necrosis. Nuclear atypia with 3 mitoses per 10 high-power fields was also noted.
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proved survival, and tumor grade, tumor size, lymph node
status, gender, and age have not.14,20
IVC leiomyosarcoma is densely adherent to the caval
wall and consists of encapsulated yellowish-tan or pinkish-
gray lobulated whorls.15 It originates in the media of the
vessel and may grow extraluminally, intraluminally, or
both.15 Mingoli et al14 documented extraluminal growth
pattern in 72.9% of cases, with a patent IVC in 57.6%. Our
case showed only intraluminal growth. Histologically, the
tumor consists of spindle-shaped interlacing bundles of
cells with bizarre-shaped nuclei and mitotic figures ar-
ranged in fascicles. The tumor cells display desmin, vimen-
tin, and smooth muscle cell actin but not S-100 pro-
tein.13,15 Focal areas of necrosis were present in more than
50% of tumors.13
This case also illustrates that thorough evaluation of
iliocaval thrombosis must be performed before primary
endovascular management. The current enthusiasm for
endovascular management with venous stents must be tem-
pered by the knowledge that residual imaging defects may
represent undiagnosed pathology. A 1-year delay in diag-
nosis occurred secondary to the acceptance of a residual
defect on completion venography. Abnormalities on com-
pletion venography mandate further evaluation or close
clinical follow-up.
Intraoperatively, the correct surgery was performed
secondary to fixation of the tumor to the IVC. Fixation to
the IVC is indicative of leiomyosarcoma and not leiomyo-
matosis. Leiomyomatosis usually is fixed to the iliac or
uterine veins and easily removed from the IVC. Fixation to
the IVC should prompt significant consideration for wide
local excision.
Leiomyosarcoma of the pararenal IVC can be success-
fully managed with wide local excision and prosthetic re-
placement. Adjuvant chemotherapy and radiation therapy
have not been definitively shown to improve survival for
IVC leiomyosarcoma. A high index of clinical suspicion
must be maintained to differentiate between these two
disease processes.
REFERENCES
1. Birsch-Hirschfeld FV. Lehrbuch der Pathologischen Anatomie, vol 1,
5th ed. Leipzig: Vogel, 1896. p. 226.
2. Norris HJ, Parmley T. Mesenchymal tumors of the uterus. V. Intrave-
nous leiomyomatosis. A clinical and pathologic study of 14 cases.
Cancer 1975;36:2164-78.
3. Merchant S, Malpica A, Deavers MT, Czapar C, Gershenson D, Silva
EG. Vessels within vessels in the myometrium. Am J Surg Pathol
2002;26:232-6.
4. Steinmetz OK, Bedard P, Prefontaine ME, Bourke M, Barber GG.
Uterine tumor in the heart: intravenous leiomyomatosis. Surgery 1996;
119:226-9.
5. Harris LM, Karakousis CP. Intravenous leiomyomatosis with cardiac
extension: tumor thrombectomy through an abdominal approach. J
Vasc Surg 2000;31:1046-51.
6. Nakayama Y, Kitamura S, Kawachi K, Kawata T, Fukutomi M, Hase-
gawa J, et al. Intravenous leiomyomatosis extending into the right
atrium. Cardiovasc Surg 1994;2:642-5.
7. Tierney WM, Ehrlich CE, Bailey JC, King RD, Roth LM, Wann LS.
Intravenous leiomyomatosis of the uterus with extension into the heart.
Am J Med 1980;69:471-5.
8. Evans AT, Symmonds RE, Gaffey TA. Recurrent pelvic intravenous
leiomyomatosis. Obstet Gynecol 1981;57:260-4.
9. Mitsuhashi A, Nagai Y, Sugita M, Nakajima N, Sekiy S. GnRH agonist
for intravenous leiomyomatosis with cardiac extension. J Reprod Med
1999;44:883-6.
10. Perl L. Ein fall von sarkom der vena cava inferior. Virchows Archiv
1871;53:378-83.
11. Dzsinich C, Gloviczki P, van Heerden JA, Nagorney DM, Pairolero PC,
Johnson CM, et al. Primary venous leiomyosarcoma: a rare but lethal
disease. J Vasc Surg 1992;15:595-603.
12. Bower TC, Stanson A. Diagnosis and management of tumors of the
inferior vena cava. In: Rutherford RB, editor. Vascular surgery. Phila-
delphia: WB Saunders Company; 2000. p. 2077-92.
13. Burke AP, Virmani R. Sarcomas of the great vessels. Cancer 1993;71:
1761-73.
14. Mingoli A, Feldhaus RJ, Cavallaro A, Stipa S. Leiomyosarcoma of the
inferior vena cava: analysis and search of world literature on 141 patients
and report of three new cases. J Vasc Surg 1991;14:688-99.
15. Kulaylat MN, Karakousis CP, Doerr RJ, Karamanoukian HL, O’Brien
J, Peer R. Leiomyosarcoma of the inferior vena cava: a clinicopathologic
review and report of three cases. J Surg Oncol 1997;65:205-17.
16. van Rooij WJJ, Martens F, Verbeeten B, Dijkstra J. CT and MR imaging
of leiomyosarcoma of the inferior vena cava. J Comput Assist Tomogr
1988;12:415-9.
17. Bretan PN, Williams RD, Hricak H. Preoperative assessment of retro-
peritoneal pathology by magnetic resonance imaging: primary leiomy-
osarcoma of inferior vena cava. Urology 1986;28:251-5.
18. Mingoli A, Sapienza P, Cavallaro A, Di Marzo L, Burchi C, Giannarelli
D, et al. The effect of extent of caval resection in the treatment of
inferior vena cava leiomyosarcoma. Anticancer Res 1997;17:3877-81.
19. Mingoli A, Cavallaro A, Sapienza P, Di Marzo L, Feldhaus RJ, Cavallari
N. International registry of inferior vena cava leiomyosarcoma: analysis
of a world series on 218 patients. Anticancer Res 1996;16:3201-5.
20. Hines OJ, Nelson S, Quinones-Baldrich WJ, Eilber FR. Leiomyosar-
coma of the inferior vena cava. Cancer 1999;85:1077-83.
Submitted May 9, 2002; accepted Jul 25, 2002.
Authors requested to declare conditions of research funding
When sponsors are directly involved in research studies of drugs and devices, the editors will ask authors to clarify the
conditions under which the research project was supported by commercial firms, private foundations, or government.
Specifically, in the methods section, the authors should describe the roles of the study sponsor(s) and the
investigator(s) in (1) study design, (2) conduct of the study, (3) data collection, (4) data analysis, (5) data
interpretation, (6) writing of the report, and (7) the decision regarding where and when to submit the report for
publication. If the supporting source had no significant involvement in these aspects of the study, the authors should
so state.
JOURNAL OF VASCULAR SURGERY
Volume 36, Number 6 Armstrong and Franklin 1259
